In this engaging discussion, Shannon Boye, a leading professor and co-founder of Atsena Therapeutics, dives into the transformative world of gene therapy for blindness. She shares fascinating insights about using viruses to deliver therapeutic genes and highlights breakthroughs, such as the trial for Leber Congenital Amaurosis type 1. Shannon also explores the brain's adaptability in processing vision after treatment and the balance between academic passion and the challenges of entrepreneurship in this groundbreaking field.